Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Sodium/glucose cotransporter 2 (SGLT2) |
Target Info
|
Modulator |
[1] |
| References |
Top |
| REF 1 |
FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 216203.
|
| REF 2 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| REF 3 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| REF 4 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
